abstract |
The present invention relates to a method of treating depression or anxiety in a mammal by administering a monoamine reuptake inhibitor in combination with a dopamine D3 receptor agonist to a mammal, including humans. The present invention also relates to pharmaceutical compositions containing pharmaceutically acceptable carriers, monoamine reuptake inhibitors and dopamine D3 receptor agonists. |